Literature DB >> 1551064

Prognostic relevance of DNA flow cytometry in oligodendroglioma.

J M Kros1, C G van Eden, C J Vissers, A H Mulder, T H van der Kwast.   

Abstract

In a retrospective study of 85 cases, the prognostic value of DNA flow cytometry in oligodendrogliomas was evaluated. Paraffin-embedded material was processed for flow cytometry, and the survival rates of the patients with DNA diploid, aneuploid, and tetraploid tumors were compared using analysis of variance. In addition, the mitotic index was correlated with the results of flow cytometry. Finally, the results of flow cytometry, histopathologic grading, and counting mitoses were tested for dependency. Thirty-one percent of the tumors were diploid, 39% were tetraploid, and 31% were aneuploid. The results of the DNA flow cytometry did not correlate with the survival times (P = 0.798) or with tumor degree. In contrast, the number of mitoses (P less than 0.05), and the grades of the grading system of Smith (P less than 0.003) had relevance for the prognosis. No correlation between flow cytometry, histopathologic grading, and mitotic index was found. It is concluded that flow cytometry has no value in predicting the biologic behavior of oligodendrogliomas, whereas the number of mitoses is a valuable prognostic parameter and thus is considered to be incorporated into the grading system for oligodendrogliomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551064     DOI: 10.1002/1097-0142(19920401)69:7<1791::aid-cncr2820690722>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Oligodendrogliomas: clinicopathological correlations.

Authors:  J M Kros
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

2.  DNA ploidy and S-phase in recurrent astrocytomas: a retrospective study by flow cytometry of deparaffinized specimens.

Authors:  L Vavruch; B Nordenskjöld; J Carstensen; S Eneström
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

3.  Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.

Authors:  D Schiffer; A Chiò; M T Giordana; T Pezzulo; M C Vigliani
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Clinical evaluation of DNA index in human brain tumors.

Authors:  T Nishizaki; N Ohshita; Y Nagatsugu; T Orita; H Ito; K Sasaki
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.